Testosterone CYP 200 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FV7V2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,134
Award facts
- Contract value 100% obligated
- $1,133.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,133.84 to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price contract, with no set-aside designation, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems.
This award reflects the company's established role as a primary pharmaceutical supplier within the DLA's global medical supply chain, which serves military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order demonstrates the routine execution of AmerisourceBergen's comprehensive IDC vehicle, under which the company supplies a broad spectrum of pharmaceutical products and medical commodities across multiple therapeutic domains on a competitively awarded basis.
Quick answers
Who was awarded contract SPE2DR26FV7V2?
SPE2DR26FV7V2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FV7V2 worth?
The government has obligated $1,134 on SPE2DR26FV7V2.
Is contract SPE2DR26FV7V2 an order under another contract?
Yes. SPE2DR26FV7V2 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7V2 competed?
The extent of competition for SPE2DR26FV7V2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award